President Donald Trump has signed two executive orders aimed at reducing the cost of prescription drugs, but pharmaceutical benefit managers have been a small part of the legislation.  Here’s what to know about the president’s approach to PBM policy so…

The FDA has approved Sanofi and Regeneron’s Dupixent as a treatment for adults with bullous pemphigoid, a rare chronic autoimmune skin condition that causes severe itching, painful blisters and open sores.  Bullous pemphigoid primarily affects older adults. Current treatments often…

Here are 11 new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

Sen. Bernie Sanders , I-Vt., and a group of more than 30 medical associations have separately requested that the Senate Health, Education, Labor and Pension Committee investigate the termination of the CDC’s vaccine advisory committee members. Four things to know:…

Nationwide, hospitals and pharmacies are seeing ongoing shortages of medications including some anesthetics, antibiotics, opioids and chronic disease treatments, FDA data shows.  As of June 19, 194 drugs were in shortage, according to the agency’s database of current and resolved…

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found that among nonspecialty medications, there was a 6.3% increase in net…

In 2024, pharmacies dispensed an estimated $265 billion in specialty medications — an 8% increase from the year prior, according to Drug Channels.  Compared to 2023, BrightSpring Health Services increased its specialty prescription revenue 42%, and PANTHERx Rare Pharmacy saw…

A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to allow them to continue making copies of the…

The median salary for hospital pharmacists in 2024 was $149,240, a 3.44% increase from $144,270, the 2023 average, according to data from the Bureau of Labor Statistics. In 2024, hospitals employed 28% of the nation’s pharmacists and paid them the…

A new report from Vizient highlighted the 10 drug shortages placing the most pressure on U.S. hospitals, with the injectable lorazepam topping the list for both general and pediatric facilities.  The following are the top 10 high-impact drug shortages reported…